We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ARAB HEALTH - INFORMA

Download Mobile App





AI Algorithms for Analyzing Chest X-ray/CT Scan Aid in Treatment of COVID-19 Infected Patients

By HospiMedica International staff writers
Posted on 07 Apr 2020
In an effort to help the medical community in the fight against COVID-19, VUNO (Seoul, South Korea), an AI medical imaging software company, is offering special versions of two AI products, VUNO Med- LungQuant and VUNO Med-Chest X-ray: COVID-19, encompassing both lung X-ray and CT modalities, respectively all at once. More...
VUNO's one-stop service offering will allow users to choose one or both algorithms to use depending on their own needs by simply visiting one website without the hassle of moving from different AI systems. The web-based services are available for free for anyone who wants to use VUNO's AI algorithms to analyze a chest X-ray or CT scan.

The common theme of the two AI solutions is to empower healthcare providers to provide better patient care by assisting them in the screening, diagnosis, and management of COVID-19 infected patients using VUNO’s AI technology. The company has developed the AI solutions to help protect healthcare providers from burnout or help overworked doctors on the edge of exhaustion in virus fight make a speedier and more accurate diagnostic decision in the current difficult time. In addition, VUNO's cloud-based service offering will enable remote result reading and tracking of the status of patients infected with COVID-19, where radiologists are not readily available. Medical institutions and healthcare providers are encouraged to make the best use of VUNO's free online service offering available at https://covid19.vunomed.com

Related Links:
VUNO


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Radiation Safety Barrier
RayShield Intensi-Barrier
Mammography System (Analog)
MAM VENUS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.